deferoxamine has been researched along with catechol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dobbin, PS; Hall, AD; Hider, RC; Porter, JB; Sarpong, P; Taylor, PD; van der Helm, D; Xiao, G | 1 |
| Abe, T; Akita, T; Kamiya, K; Katoh, S; Kodama, I; Toyama, J | 1 |
| Alvarez, LD; Clarêncio, J; Costa, MF; Costa, SL; El-Bachá, RS; Lima, RM | 1 |
3 other study(ies) available for deferoxamine and catechol
| Article | Year |
|---|---|
Synthesis, physicochemical properties, and biological evaluation of N-substituted 2-alkyl-3-hydroxy-4(1H)-pyridinones: orally active iron chelators with clinical potential.
Topics: Administration, Oral; Animals; Crystallography; Deferoxamine; Horses; Humans; Iron; Iron Chelating Agents; Liver; Mice; Pyridones; Rats; Stereoisomerism; Structure-Activity Relationship | 1993 |
Protective action of iron-chelating agents (catechol, mimosine, deferoxamine, and kojic acid) against ischemia-reperfusion injury of isolated neonatal rabbit hearts.
Topics: Animals; Animals, Newborn; Catechols; Creatine Kinase; Deferoxamine; Electron Spin Resonance Spectroscopy; Free Radicals; Heart; In Vitro Techniques; Iron Chelating Agents; Mimosine; Myocardial Reperfusion Injury; Myocardium; Pyrones; Rabbits; Ventricular Function, Left | 1992 |
Cytotoxic effects of catechol to neuroblastoma N2a cells.
Topics: Animals; Antioxidants; Apoptosis; Ascorbic Acid; Catechols; Cell Line, Tumor; Cell Survival; Curcumin; Cysteine; Cytotoxins; Deferoxamine; Glutathione; Mice; Neuroblastoma; NF-kappa B; Reactive Oxygen Species; Sesquiterpenes; Superoxide Dismutase | 2008 |